提高结核病患者的安全:基于跨专业合作的远程医疗对随机对照试验中与药物相关问题的影响
Devi Ristian Octavia1, Andi Hermansyah2, Yunita Nita2
1Doctoral Study Program of Pharmaceutical Science, Faculty of Pharmacy Universitas Airlangga, Kampus C UNAIR, Jl. Mulyorejo, Mulyorejo, Surabaya, East Java, 60115, Surabaya, Indonesia; Faculty of Health Sciences Universitas Muhammadiyah Lamongan, Jl. Raya Plalangan KM 02 Plosowahyu Lamongan, East Java, 62218, Indonesia.
The Indian journal of tuberculosis
|March 14, 2026
概括
基于远程医疗的跨专业合作显著减少了结核病患者与药物相关的问题. 这种方法通过改善药物不良反应,药物相互作用和坚持来提高患者的安全性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
- 远程医疗远程医疗
背景情况:
- 复杂结核病 (TB) 治疗增加了与药物相关问题的风险.
- 最佳的结核病管理需要一个多学科的团队,往往缺乏医院设置.
- 这项研究调查了基于远程医疗的专业间合作 (IPC) 以减轻结核病患者的DRPs.
研究的目的:
- 分析基于远程医疗的IPC实践对减少结核病患者的DRP发病率的影响.
- 评估通过远程护理提供的多学科团队方法的有效性.
- 在复杂的结核病治疗方案中提高患者安全.
主要方法:
- 一个单面罩的随机对照试验,有300名参与者和1:1分配.
- 干预组接受了基于远程护理的IPC;对照组接受了标准护理.
- 主要结局:DRP的发生率 (不必要的治疗,需要额外的治疗,无效的治疗,剂量问题,不良药物反应,不遵守).
主要成果:
- 基于远程医疗的IPC显著降低了DRP发病率 (p<0.05).
- 观察到的药物不良反应,药物相互作用和不坚持的显著减少.
- 该干预措施对患者安全产生了积极影响.
结论:
- 基于远程医疗的IPC是减少结核病患者的DRPs的有效策略.
- 这种模型可以提高患者的安全性和治疗结果.
- 应考虑在复杂的结核病管理中实施基于远程医疗的多学科团队.
相关概念视频
Pulmonary Tuberculosis V
730
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
730
Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis IV
612
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
612
Therapeutic Drug Monitoring: Affecting Factors
313
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
313
Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K


